国际麻醉学与复苏杂志   2015, Issue (2): 6-6
    
糖原合成激酶3β在二氮嗪后处理糖尿病大鼠 心肌缺血/再灌注损伤中的作用
张琳, 叶英, 许铁, 范群雄, 于红丽1()
1.徐州医学院
The role of glycogen synthase kinase-3β in myocardial ischemia/reperfusion injury in diazoxide postconditioned diabetic rats
 全文:
摘要:

目的 观察糖原合成激酶3β(glycogen synthase kinase-3β, GSK-3β)在二氮嗪(diazoxide, DZ)后处理糖尿病大鼠心肌缺血/再灌注损伤(ischemia/reperfusion injury, I/RI)中的作用及机制。 方法 单次腹腔注射链脲佐菌素(streptozotocin, STZ)制备糖尿病大鼠模型,取造模成功的大鼠48只,复制在体心肌缺血/再灌注(ischemia/reperfusion, I/R)模型,按随机数字表法分为4组(每组12只):假手术组(Sham组)、I/R组(I组)、DZ组(D组)、SB216763+DZ组(S组)。连续监测血流动力学指标,比色法测血浆乳酸脱氢酶(lactate dehydrogenase, LDH)活性,2,3,5-氯化三苯基四氮唑(triphenyl tetrazolium chloride, TTC)染色分析心肌梗死面积,Western blot测磷酸化GSK-3β(phosphorylated GSK-3β, pGSK-3β)的表达。 结果 与I组及D组比较,S组心功能明显改善(P<0.05),血浆LDH[S组、I组、D组为(5 335±502)、(7 943±831)、(7 176±521) U/L,P<0.05]活性及心肌梗死面积[S组、I组、D组为(21.0±1.6)%、(30.8±3.8)%、(31.3±2.9)%,P<0.05]均显著降低,pGSK-3β表达增加(P<0.05);I组与D组比较上述指标差异无统计学意义(P>0.05)。 结论 DZ后处理对糖尿病大鼠心肌I/RI无保护作用,GSK-3β抑制剂干预后DZ后处理对糖尿病大鼠心肌I/RI的保护作用恢复。

关键词: 糖原合成激酶3β; 二氮嗪; 糖尿病大鼠; 缺血/再灌注损伤
Abstract:

Objective To observe the role and mechanism of glycogen synthase kinase-3β(GSK-3β) in myocardial ischemia/reperfusion injury(I/RI) by diazoxide(DZ) postconditioning in diabetic rats. Methods The diabetic rat model was established by single intraperitoneal injection of streptozotocin. After the model was duplicated successfully, in vivo myocardial ischemia/reperfusion(I/R) model was developed in 48 rats. Then the rats were randomly divided into 4 groups(n=12): sham operation group(group Sham), I/R group(group I ), DZ group(group D), SB216763 and DZ group(group S). Hemodynamic parameters were monitored continuously. The plasma cardiac enzymes lactate dehydrogenase(LDH) and myocardial infarct size were measured by colorimetric measurement and 2,3,5-triphenyltetrazolium chloride(TTC) staining, respectively. The protein expression of phosphorylated GSK-3β(pGSK-3β) in the heart was detected by Western blot. Results Compared with group I and group D, cardiac function was improved in group S(P<0.05). The levels of plasma LDH [group S vs group I vs group D: (5 335±502) U/L vs (7 943±831) U/L and (7 176±521) U/L, P<0.05] and myocardial infarct size[group S vs group I vs group D: (21.0±1.6)% vs (30.8±3.8)% and (31.3±2.9)%, P<0.05] significantly decreased. The expression of pGSK-3β was increased(P<0.05). There was no significant difference between group I and D(P>0.05). Conclusions DZ postconditioning can't protect diabetic rat heart against I/RI, but can exert the protective function after interfered with GSK-3β inhibitor.

Key words: Glycogen synthase kinase-3β; Diazoxide; Diabetic rats; Ischemia/reperfusion injury